Matthew Rose-Zerilli

9PUBLICATIONS
77CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyCell and nuclear divisionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

|Sep 08, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial.

Lara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli

|May 03, 2025
Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance.

Joanna C Fowler, Roshan K Sood, George Coltart

|Feb 14, 2022
Comparison of optimized methodologies for isolating nuclei from esophageal tissue.

Lucy M Kimbley, Rachel Parker, Jack Harrington

|Jul 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment.

Malgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key

|Jul 29, 2021
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma.

Jonathan C Strefford, Malgorzata Nowicka, Chantal E Hargreaves

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan C Strefford

3 joint publications

Mark S Cragg

2 joint publications

Lara E Buermann

2 joint publications

Eugene Healy